Comparison of the anti-arrhythmia activity of novocainamide and obzidan in patients with ventricular extrasystole
Sumarokov, A.B.
Kardiologiia 23(11): 56-59
1983
ISSN/ISBN: 0022-9040 PMID: 6197558 Document Number: 202565
Comparative efficiency of obsidan, novocainamide and placebo was studied in patients with ventricular extrasystole of varying origins. Obsidan administered in a dose providing a beta-blocking effect is no less effective than novocainamide in terms of antiarrhythmic activity. Owing to this level of efficiency, obsidan can be recommended for long-term treatment of ventricular extrasystole.
Document emailed within 1 workday
Related Documents
Savina, M.D.; Kudrin, A.N. 1982: Anti-arrhythmia activity of fusaric acid N,N-diethylaminoethylamide in experimental arrhythmia models in comparison with novocainamide Farmakologiia i Toksikologiia 45(2): 63-65Korkushko, O.V.; Butenko, A.G. 1983: Use of obzidan in continuous cardiac fibrillation and extrasystole in middle-aged and elderly patients with ischemic heart disease Klinicheskaia Meditsina 61(11): 34-40
Sokolov, S.F.; Golitsyn, S.P.; Malakhov, V.I.; Bankuzov, V.A.; Koltunova, M.I.; Golitsyn, L.S. 1990: The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor Farmakologiia i Toksikologiia 53(3): 57-60
Laurent, M.; Miane, B.; Almange, C.; Leborgne, P. 1982: Comparison of data from exercise tests and continuous electrocardiographic recording in patients with ventricular extrasystole. Apropos of 131 cases Archives des Maladies du Coeur et des Vaisseaux 75(6): 653-662
Leclercq, J.F.; Attuel, P.; Milosevic, D.; Coumel, P. 1979: Quantitative evaluation of the efficacy of anti-arrhythmia agents in chronic ventricular arrhythmia Acta Cardiologica 34(1): 35-50
Bracchetti, D.; Mantovani, B.; Naccarella, F.; Lombardi, G.; Palmieri, M. 1980: Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia Bollettino Della Societa Italiana di Cardiologia Suppl: 117-123
Mazur, N.A.; Kurbanov, R.D. 1984: Deterioration in ventricular arrhythmia caused by anti-arrhythmia preparations Terapevticheskii Arkhiv 56(9): 67-70
Storozhuk, B.G. 1985: Anti-arrhythmia activity and side effects of various anti-arrhythmia agents Vrachebnoe Delo 3: 41-44
Raviele, A.; Di Pede, F.; Piccolo, E. 1985: Protocol of the serial electropharmacological study for selecting the most efficacious chronic anti-arrhythmia therapy in patients with sustained recurrent ventricular tachycardia and in survivors of cardiac arrest secondary to ventricular tachycardia Giornale Italiano di Cardiologia 15(3): 354-357
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Occhetta, E. 2000: The benefits of the implantable cardioverter-defibrillator in comparisons with anti-arrhythmia agents in patients surviving malignant ventricular tachyarrhythmias: a subanalysis of the AVID study by varying degrees of left ventricular dysfunction. Antiarrhythmic versus Implantable Defibrillators Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 1(4): 577-578
Naccarella, F.; Palmieri, M.; Nanni, G.; Barbato, G.; Casella, G.; Bartoletti, A.; Bracchetti, D. 1987: Sustained ventricular tachycardia: epidemiological, clinical and prognostic aspects. Long-term follow up of different subgroups of patients under anti-arrhythmia therapy. i Cardiologia 32(1): 55-64
Jaillon, P.; Simon, T. 1992: Ventricular pro-arrhythmic effects of anti-arrhythmia drugs Therapie 47(3): 187-192
Steinbeck, G. 1991: Which anti-arrhythmia agent in continuous ventricular tachycardia? Medizinische Klinik 86(12): 659-660
Tuna, J.L. 1992: Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 385-386
Aupetit, J.F.; Timour, Q.; Chevrel, G.; Omar, S.; Loufoua-Moundanga, J.; Faucon, G. 1993: Comparative study of different classes of anti-arrhythmia agents on the vulnerability of ischemic ventricular fibrillation Therapie 48(4): 403-407
Golitsyn, S.P.; Malakhov, V.I.; Bakalov, S.A.; Sokolov, S.F.; Krutanov, I.B.; Levin, E.R.; Mikhaĭlova, G.A.; Chernousova, T.V. 1991: The diagnosis and possibilities for the anti-arrhythmia treatment of malignant ventricular disorders of the heart rhythm Terapevticheskii Arkhiv 63(9): 38-44
Steinbeck, G. 1992: Which patient with sustained ventricular tachycardia is suited for long-term therapy with anti-arrhythmia drugs? Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 47(5): 195-201
Du, Z.H.; Liu, H.G.; Zeng, F.D.; Hu, C.J. 1988: Effects of dauricine combined with other anti-arrhythmia agents on electrically induced ventricular fibrillation in rabbits Zhongguo Yao Li Xue Bao 9(1): 33-36
Satullo, G.; Donato, A.; Busà, G.; Mangano, S.; Cavallaro, L. 1993: The allorhythmic distribution of ectopic ventricular beats. Observations on the electrogenesis and dynamics of concealed ventricular extrasystole Giornale Italiano di Cardiologia 23(9): 887-897